Ibogamine-18-methanol,14-[(3aR,6R)-2,3,3a,4,5,6-hexahydro-1H-indolo[3,2,1-de][1,5]naphthyridin-6-yl]-13-hydroxy-(9CI) (76202-21-6)

Identification
Name:	Ibogamine-18-methanol,14-[(3aR,6R)-2,3,3a,4,5,6-hexahydro-1H-indolo[3,2,1-de][1,5]naphthyridin-6-yl]-13-hydroxy-(9CI)
Synonyms:	Ibogamine-18-methanol,14-(2,3,3a,4,5,6-hexahydro-1H-indolo[3,2,1-de][1,5]naphthyridin-6-yl)-13-hydroxy-,[14(3aR,6R)]-; 1H-Indolo[3,2,1-de][1,5]naphthyridine, ibogamine-18-methanolderiv.; 6,9-Methano-5H-pyrido[1',2':1,2]azepino[4,5-b]indole,ibogamine-18-methanol deriv.; Bonafousinol
CAS:	76202-21-6
Molecular Formula:	C34H40 N4 O2
Molecular Structure:
Properties
Safety Data

Other Product

Ibogamine-18-methanol,14-[(2R,3aR)-2,3,3a,4,5,6-hexahydro-1H-indolo[3,2,1-de][1,5]naphthyridin-2-yl]-13-hydroxy-(9CI)
Ibogamine-18-carboxylicacid,14-[(2R,3aR)-2,3,3a,4,5,6-hexahydro-1H-indolo[3,2,1-de][1,5]naphthyridin-2-yl]-13-hydroxy-,methyl ester (9CI)
methyl (2alpha)-14-[(3aR,6R)-2,3,3a,4,5,6-hexahydro-1H-indolo[3,2,1-de][1,5]naphthyridin-6-yl]-13-hydroxyibogamine-18-carboxylate
ethyl 2-((3aR,4S)-4-ethyl-4-(2-methoxy-2-oxoethyl)-6-oxo-3a,4,5,6-tetrahydro-1H-indolo[3,2,1-de][1,5]naphthyridin-3(2H)-yl)acetate
3-methyl-6-prop-2-en-1-yl-2,3,3a,4,5,6-hexahydro-1H-indolo[3,2,1-de][1,5]naphthyridin-6-ol
Ibogamine-18-carboxylicacid, 13-methoxy-14-[(3a)-17-methoxy-17-oxovobasan-3-yl]-19-(2-oxopropyl)-, methyl ester (9CI)
3-prop-2-en-1-yl-1,2,3,3a,4,5-hexahydro-6H-indolo[3,2,1-de][1,5]naphthyridin-6-one hydrochloride
3-[(2E)-but-2-en-1-yl]-1,2,3,3a,4,5-hexahydro-6H-indolo[3,2,1-de][1,5]naphthyridin-6-one hydrochloride
3-prop-2-yn-1-yl-1,2,3,3a,4,5-hexahydro-6H-indolo[3,2,1-de][1,5]naphthyridin-6-one hydrochloride
Pentanoic acid,5-[(2Z,3aR,5R,6R,6aR)-3a-ethynylhexahydro-5-hydroxy-6-(3-hydroxy-1-octenyl)-2(1H)-pentalenylidene]-,calcium salt (2:1), (1E,3S)- (9CI)
1H-3a,6-Epoxyazulen-2(3H)-one,hexahydro-3,8-dimethyl-5-(1-methylethenyl)-, (3S,3aR,5R,6R,8S,8aR)- (9CI)
1H-3a,6-Epoxyazulen-2(3H)-one,hexahydro-3,8-dimethyl-5-(1-methylethenyl)-, (3S,3aR,5R,6R,8S,8aS)- (9CI)
Ibogamine-18-carboxylicacid, 14-[(3a,20b)-19,20-dihydro-17-methoxy-17-oxovobasan-3-yl]-13-methoxy-19-(2-oxopropyl)-,methyl ester, (19R)- (9CI)
1H-3a,6-Epoxyazulen-2(3H)-one,hexahydro-5-(1-hydroxy-1-methylethyl)-3,8-dimethyl-, (3S,3aR,5S,6R,8S,8aS)-(9CI)
1,3-Benzodioxole-5-carboxaldehyde,6-[(3S,3aR,6R,7aR)-1,2,3,6,7,7a-hexahydro-3-hydroxy-6-methoxy-1-methyl-3aH-indol-3a-yl]-4-methoxy-
(3aR)-3-[(3R)-3-hydroxybutyl]-1,2,3,3a,4,5-hexahydro-6H-indolo[3,2,1-de][1,5]naphthyridin-6-one
Ibogamine-18-carboxylicacid, 13-methoxy-14-[(3a)-17-methoxy-17-oxovobasan-3-yl]-19-oxo-, methyl ester (9CI)
2(5H)-Furanone,5-[[(1S,3aR,4R,6R)-1,2,3,4,5,6-hexahydro-1,5,5-trimethyl-3a,6-ethano-3aH-inden-4-yl]methylene]-3-methyl-,(5Z)- (9CI)
Pentanoic acid,5-[(3aS,5R,6R,6aR)-hexahydro-5-hydroxy-6-[(1E,3S)-3-hydroxy-1-octenyl]-3a-methyl-2(1H)-pentalenylidene]-,calcium salt (2:1), (5Z)- (9CI)
Dynorphin A (swine),13-[N6-[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]-L-lysinamide]-14-de-L-tryptophan-15-de-L-asparticacid-16-de-L-asparagine-17-de-L-glutamine-, [3aS-(3aa,4b,6aa)]- (9CI)